IP Library Granted Patent US 10,792,340
Granted Patent B2
US 10,792,340 · App. 15/563,795 · Granted Oct 6, 2020

Antibacterial composition for combating carbapenem-resistant gram-negative bacteria comprising ADK protein as active ingredient

Inventors: Yeong Min Park (Seoul, KR); In Duk Jung (Cheongju-si, KR); Seung Jun Lee (Yeongju-si, KR)
Assignee: KONKUK UNIVERSITY GLOCAL INDUSTRY-ACADEMIC COLLABORATION FOUNDATION
A61K38/45A01N63/10A23L33/17A61K8/98A61K35/66A61P31/04C12Y207/04003A23V2002/00Y02A50/473
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,792,340
App. No.
15/563,795
Granted
Oct 6, 2020
Kind
B2
Abstract

Provided is an antibacterial composition against carbapenem-resistant gram-negative bacteria which includes, as an active ingredient, adenylate kinase (ADK) protein derived from Mycobacterium tuberculosis . The ADK protein derived from Mycobacterium tuberculosis , according to the subject matter, has excellent antimicrobial activity against carbapenem-resistant gram-negative bacteria, and thus may be usefully used in a variety of fields as an antibacterial composition.

Claims (8)

1. A method of treating an infectious disease caused by carbapenem-resistant gram-negative bacteria comprising administering a composition comprising adenylate kinase (ADK) protein as an active ingredient to a subject in need thereof.

2. The method of claim 1 , wherein the ADK protein is derived from Mycobacterium tuberculosis.

3. The method of claim 1 , wherein the ADK protein is represented by SEQ ID NO: 1.

4. The method of claim 1 , wherein the ADK protein is encoded by a base sequence represented by SEQ ID NO: 2.

5. The method of claim 1 , wherein the infectious disease caused by carbapenem-resistant gram-negative bacteria is selected from the group consisting of pneumonia, peritonitis, meningitis, wound infections, osteoarthritis, cholecystitis, urinary tract infections, cerebromeningitis, endocarditis, myocarditis, pericarditis, arthritis, pharyngitis, gonorrhea, bacillary dysentery, enteritis, conjunctivitis, gastritis, tympanitis, cystitis, lymphangitis, and septicemia.

6. The method of claim 1 , wherein the composition is an antibacterial quasi-drug composition, antibacterial food additive, antibacterial feed additive composition, pharmaceutical composition or food composition.

7. A method of alleviating an infectious disease caused by carbapenem-resistant gram-negative bacteria comprising administering a composition comprising adenylate kinase (ADK) protein as an active ingredient to a subject in need thereof.

8. The method of claim 7 , wherein the composition is an antibacterial quasi-drug composition, antibacterial food additive, antibacterial feed additive composition, pharmaceutical composition or food composition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2017
From: PARK, YEONG MIN; JUNG, IN DUK; LEE, SEUNG JUN
To: KONKUK UNIVERSITY GLOCAL INDUSTRY-ACADEMIC COLLABORATION FOUNDATION
Reel/Frame 043757/0160 →
Priority Claims (1)
KR 10-2015-0047360 · Apr 3, 2015 · national
Continuity (1)
Related Publication 20180078619A1 · Mar 22, 2018